ADAGENE CEO Buys 20,290 ADS at $3.15, Signaling Confidence in Oncology Pipeline
CEO Luo Peter’s recent ADAGENE share purchases signal confidence in its oncology pipeline, hinting at upside as clinical milestones approach.
3 minutes to read
ADAGENE INC